Due to the robust upregulation of AREG and its role in the tumor progression of different cancer types, which highlights its suitability as a therapeutic target, we further examined whether AREG mediates the effects of induced CD133 expression in melanoma stem cells. The gene discussed is AREG; the disease is neoplasm.